On behalf of International Pharmacy Conference 2016, organizing committee invites analytical expertise researchers, professors, scientific communities, delegates, students, business professionals and executives to attend the “International pharmacy Conference” which is to be held during July 14-15, 2016 Philadelphia, USA.

In the light of this theme, the conference series aims to provide a forum for International researchers from various areas of Pharmacy, Medical, Health science and Life science by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of pharmacy.

The conferences provide a platform to detail the research work of expertise from various scientific backgrounds and the same can be perceived by young researchers and students. The conference mainly aims to provide knowledge on Pharmacy and unveil the roles and responsibilities of pharmacist.  In course of research work and therefore Pharmacy 2016 would be a perfect venue to share and develop knowledge on Pharmacy.

The pharmaceutical Industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is evident. The total level of pharmaceutical revenue worldwide had reached nearly one trillion U.S. dollars. North America is responsible for the largest portion, generating more than 40 percent of these revenues. This is mostly due to the leading role of the U.S. pharmaceutical industry. But as in many other industries, the Chinese pharmaceutical sector shows the highest growth rates over the last years. The global pharmaceuticals market is worth US$300 billion a year, a figure expected to rise to US$400 billion within three years. By 2020 the pharmaceutical market is anticipated to more than double to US$1.3 trillion, with the E7 countries — Brazil, China, India, Indonesia, Mexico, Russia and Turkey — accounting around for one fifth of global pharmaceutical sales. Further, incidence of chronic conditions in the developing world will increasingly resemble those of the developed world.

OMICS international organises 1000+ global events every year across the globe with support from 1000+ more scientific societies and publishes 700 open access journals which contain over 50000 eminent personalities , reputed scientists as editorial board members.

Why to attend ?

As Pharmaceutical care moves to a more patient centred model it becomes extremely important to ensure an adequate and professional pharmacy practice. Pharmacists, in one hand, need to ensure maximum use of their skills by embarking on a culture of lifelong learning. On the other hand, it becomes evident that all members of the healthcare system need to co-operate to ensure planning, implementation and monitoring of a therapeutic plan that focuses on effective patient outcome. International pharmacy conference reinforces the importance of collaboration and dialogue between Policy Makers, Stakeholders, Regulators and Pharmaceutical experts.

Target Audience: 

• Students, Scientists, Researchers, and Faculty of pharmaceutical
• Universities, Medical colleges, Researchers from pharmaceutical
• Companies, Pharmacy associations and societies, Business
• Entrepreneurs, Training institutes, Software developing companies,
• Manufacturing medical devices companies, CRO and Data
• Management companies

Summary: Pharmacy 2016 welcomes attendees, presenters, and exhibitors from all over the world to Philadelphia, USA. We are delighted to invite you all to attend and register for the “International Pharmacy Conference- 2016” which is going to be held during July 14-15, 2016 at Philadelphia, USA. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the International Pharmacy Conference 2016, where you will be sure to have a meaningful experience with scholars from around the world. All the members of International Pharmacy Conference 2016 organizing committee look forward to meet you at Philadelphia, USA. 

Importance and scope: With the development of specific and potent synthetic drugs, the emphasis of the pharmacist’s responsibility has moved substantially towards the utilization of scientific knowledge in the proper use of modern medicines and the protection of the public against dangers that are inherent in their use. Pharmacists are employed in regulatory control and drug management, community pharmacy, hospital pharmacy, the pharmaceutical industry, academic activities, training of other health workers, and research. In all these fields, their aim is to ensure optimum drug therapy, both by contributing to the preparation, supply and control of medicines and associated products, and by providing information and advice to those who prescribe or use pharmaceutical products.

Why Philadelphia USA: Greater Philadelphia is home to some of the top names in biotechnology and pharmaceutical companies. These leading firms in the region play an important role in growing and sustaining the local innovation pipeline. And, with a growing healthcare industry sector, an increasing academic technology transfer and world-class colleges and universities with strong R&D programs, Greater Philadelphia’s presence in pharmaceuticals remains one of the strongest in the world. According to the 2009 Milken Study, the growth of Greater Philadelphia’s life sciences cluster is primarily the result of its position as a major centre for the U.S. pharmaceutical industry and its strong local research infrastructure, which includes some of the nation’s top-ranked universities. Philadelphia, Pennsylvania is one of the largest cities defined as a hub for biomedical and pharmaceutical firms. Local economies have seen rapid growth in health, research, and education sectors and relatively low unemployment rates in recent years in comparison to other cities of the same demographics. As home to the Academy and College of Philadelphia founded by Benjamin Franklin as the first medical school during 1749, Philadelphia has a longstanding legacy as a leader in medical and pharmaceutical industries. The city’s extensive medical system also features the University of Pennsylvania’s largest teaching hospital with affiliations based in the Temple University School of Medicine, Drexel University College of Medicine, Thomas Jefferson University, and the Philadelphia College of Osteopathic Medicine. Philadelphia also supports numerous pharmaceutical organizations like GlaxoSmith Kline, Wyeth, Merck, Johnson and Johnson as well as numerous professional medical association headquarters.

Pharmaceuticals in Greater Philadelphia by the numbers:

15 leading pharmaceutical firms; 11 are headquarters

700 core life science companies

39,300 direct employment in the core life sciences

139 companies received over $45 million in funding in the 2010 federal Qualified Therapeutic Discovery Project Program

$2.6 billion in R&D spending in 2008

Conference Highlights:

Pharmacy Forecast

Fundamentals Of pharmacy

Pharmacy Field

Pharmaceutical Industry’s

Pharma Reasearch & Development companies

Pharmaceutical Manufacturing

Pharmacy practice

Pharma clinical trails

Regulatory affairs

Pharma marketing

Internet pharmacy

Entrepreneurs Investment Meet

Global Pharmaceutical Companies in Philadelphia:

AstraZeneca

Bristol-Myers Squibb

GlaxoSmithKline

Johnson & Johnson

Merck

Novo Nordisk

Sanofi Aventis

Shire

Teva Pharmaceuticals

Pfizer

Universities in Philadelphia:

Philadelphia College of pharmacy

Jefferson School of Pharmacy

Temple University

Nesbitt School of pharmacy

South Carolina College of pharmacy

Touro University

University of the pacific

Arnold & Marie Schwartz College of Pharmacy and Health Sciences

Wayne state University

Societies in Philadelphia:

American Cancer Society

Philadelphia ethical society

American diabetes association

American Heart Association

Leukemia and lymphoma society

American Association of colleges of pharmacy

American pharmacist association

American society of pharmacy law

American society of consultant pharmacy foundation

American society of health system pharmacists

National Community pharmacists association

Professional compounding centres of America

American society for automation on pharmacy

Generic Drug Producers – Discover Top Companies Revenue Prospects Now, Benefiting Your Influence
What does the future hold for manufacturers and sellers of generic medicines? show you leading companies prospects to 2025. That study lets you discover results, trends, opportunities and revenue forecasts, helping you stay ahead in knowledge.

For leading producers and marketers of generic drugs, you find information on established and rising companies. Explore their sales potentials in the generics market, seeing from 2015 to 2025 the prospects of industry leaders. What revenues are possible?
In our study you find analytical profiles of top generics producers. By region you analyse historical data, activities, revenue forecasts and growth rates. Discover qualitative analysis too. Our new analysis shows you the most lucrative parts of the world industry for generic drugs. See today how you can benefit your research, analyses, decisions, proposals and presentations, also saving time and benefiting your reputation for insight.

Assessments of top companies – capabilities, results, competition and sales potentials
Our report assesses 43 leading manufacturers of generic medicines worldwide. In general a company profile gives you the following information:
• Discussion of activities, technologies and recent financial results
• Assessment of developments – mergers and acquisitions (M&A), new products, outlooks, challenges and plans
• Forecasting of generic drug revenues to 2025 (for 19 leading companies).

Discover capabilities, progress and prospects of top generics companies, grouped by region, helping you stay ahead in commercial knowledge and influence. Our study explains the changing generics industry from 2015 to 2025, including opportunities.

For the top 50 generic drug manufacturers in 2014, discover revenues and rankings. Also see top companies’ gross profit margins, EBITDA margins and historical revenue growth.

 

    

 

    

North America – outlooks for leading generic drug producers and sellers
First our report analyses 13 North American generics specialists and big pharma companies in that market, including these firms:
• Mylan
• Pfizer
• Abbott
• Hospira
• Apotex
• Par Pharmaceuticals.

In that analysis you find where revenue growth occurs and how high sales can go. Many opportunities remain, with high, expanding revenues possible from 2015.

Europe – prospects for leading generics players
Our survey also shows you outlooks for 10 European generics specialists and pharmaceutical leaders in that industry, including these firms:
• Novartis (Sandoz)
• Actavis
• Sanofi
• Fresenius Kabi
• Pharmstandard
• Gedeon Richter
• Stada Arzneimittel.

 

 

 

Welcome Message

On behalf of the Organizing Committee I have the great pleasure to extend my warm welcome to all distinguished guests from all over the world to the International Pharmacy Conference (Pharmacy 2016). This conference, being held July 14-15, 2016 Philadelphia, Pennsylvania, USA is the continuation of a highly successful series of global meetings about Pharmaceutical Sciences which is being organized by Conference series LLC, a renowned and leading organization specialized in launching and managing pharmaceutical conferences throughout the globe.

Pharmacy 2016 will be attended by over 300 participants involving academic and industrial scientists, industrial experts and decision-makers. 3 Keynote Speakers and over 50 Plenary Speakers will introduce and discuss cutting edge developments in a large number of areas among them pre-formulation, delivery routes, drug delivery technology including major challenges and relevant physiological considerations, drug targeting, nanopharmaceuticals and diverse applications of nanotechnology in pharmaceutical research and development, drug delivery systems applied to vaccine development, biotherapeutics-drug discovery, smart delivery systems and medical devices, delivery methods for biologics as well as addressing of current global drug policy. We have formed an alliance to harness the potential of an effective multi-constituency membership. Let's capitalize on that.

Our theme of the conference “Innovations in Exertions of Pharmacy” aims to sustained long term human health as well as revaluate of investing in the pharmaceutical workforce. Attendees will hear world-class speakers discussing the challenges and opportunities facing the newly developed drug. The business & academic experts who are from home and abroad will give excellent keynote speeches.

I am looking forward to a highly interesting and informative meeting, to critical and above all stimulating deliberations and last but not least to getting to know many new colleagues working in a field dear to all of us.

Respectfully,

Shinichiro Akiyama

General Director

Saisei Mirai Clinic

Japan